You are here: Industry Insights > COVID-19

News List

Kamada and Kedrion to develop immunoglobulin product for Covid-19 pharmaceutical-technology
April 30, 2020
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product for potential Covid-19 treatment.
Pneumagen reports positive lab data of Covid-19 drug candidates pharmaceutical-technology
April 30, 2020
University of St Andrews spin-out Pneumagen has reported positive findings from three in-vitro studies of Neumifil and other multivalent carbohydrate binding modules (mCBMs) to prevent infection by coronaviruses, including SARS-CoV-2.
Shionogi works on Covid-19 therapies and vaccine pharmaceutical-technology
April 30, 2020
Japanese-based Shionogi has partnered with public institutions, academia and other companies to develop potential drugs and vaccine against Covid-19.
University of Queensland reports positive findings on Covid-19 vaccine pharmaceutical-technology
April 30, 2020
The University of Queensland in Australia has reported positive findings from early preclinical testing of its Covid-19 vaccine candidate.
DCGI approves Glenmark’s clinical trials of Favipiravir Antiviral tablets for COVID-19 patients expresspharma
April 30, 2020
The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation.
AI can play a big role in vaccine development for COVID-19 expresspharma
April 30, 2020
Many believe that AI has the potential to complement the scientific community in major breakthroughs, especially in developing vaccines for COVID-19.
Sesderma communicates the effectiveness of Lactyferrin Forte Solution for COVID-19 expresspharma
April 30, 2020
Lactyferrin (LF) is known to exhibit medicinal properties and strengthen the immune system.
Catalent, J&J Enter Mfg. Pact for COVID-19 Vax Candidate contractpharma
April 30, 2020
Includes joint investment and tech transfer to prepare for rapid scale-up and cGMP commercial manufacturing at Catalent's Bloomington facility.
PPD Extends Digital Clinical Trial Capabilities contractpharma
April 30, 2020
New clinical study models aim to support biopharma companies’ research continuity during COVID-19 pandemic.
How Fette Compacting China supports the Battle against COVID-19 PhamraSources.com
April 30, 2020
The global pandemic of COVID-19 has changed the focus towards epidemic prevention and control of the infection in all areas of the world.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page